Triple-negative breast cancer (TNBC) is a heterogeneous and aggressive subtype of breast cancer that lacks the expression of estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor receptor 2 (HER2). Here, ESR1 is linked to breast cancer.